Tandem Diabetes Care | TNDM - Trade Creditors


Tandem Diabetes Care reported $59.86M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
Accuray USD 43.52M 1.12M Dec/2025
Align Technology USD 109.84M 13.88M Jun/2026
AtriCure USD 78.74M 8.68M Jun/2026
Baxter International USD 1.03B 52M Jun/2026
Becton, Dickinson and Co. USD 5.93B 204M Mar/2026
Boston Scientific USD 1.23B 90M Jun/2026
Cooper Companies USD 233.3M 7.5M Mar/2026
Dexcom USD 2.08B 134.8M Jun/2026
Edwards Lifesciences USD 210.5M 29.4M Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Globus Medical USD 106.94M 3.28M Jun/2026
ICU Medical USD 149.16M 24.82M Jun/2026
Inogen USD 21.22M 684K Sep/2025
Insulet USD 123.3M 26.5M Jun/2026
Integra LifeSciences USD 82.64M 5.31M Jun/2026
Intuitive Surgical USD 1.92B 66.6M Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Medtronic USD 2.57B 12M Dec/2025
Merit Medical Systems USD 70.74M 2.88M Jun/2026
Orthofix International USD 63.53M 8.84M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Stryker USD 1.59B 207M Mar/2026
Tandem Diabetes Care USD 59.86M 12.79M Mar/2026
Teleflex USD 143.29M 335K Jun/2026
Zimmer Biomet Holdings USD 352.4M 8.8M Jun/2026